Skip to main content

Global Gastrointestinal Devices Market to Witness 7% CAGR Growth on Expanding GI Screenings 2030

 


The global gastrointestinal devices market is projected to grow at a CAGR of ~7% during the forecast period. This expansion is fueled by an aging population, an increasing prevalence of gastrointestinal diseases, and a surge in minimally invasive procedures. The rise in early disease screening programs, especially for colorectal cancer, is significantly driving device adoption. However, factors such as stringent regulatory approvals and the high cost of advanced GI procedures may limit market growth in certain regions. 

Gastrointestinal (GI) devices refer to specialized instruments designed to diagnose, monitor, and treat digestive system disorders. These include endoscopic devices, biopsy forceps, enteral feeding tubes, hemostatic devices, and GI stents, among others. Their primary purpose is to provide minimally invasive solutions that improve diagnostic accuracy and therapeutic outcomes while reducing patient discomfort. The sector has witnessed continuous innovation, such as AI-powered endoscopic imaging, robotic-assisted surgeries, and advanced biodegradable stents, improving both patient care and procedural efficiency.

Click here to get our sample PDF report for Medical Devices market:
https://meditechinsights.com/gastrointestinal-devices-market/request-sample/

Increasing gastrointestinal disease burden fuelling market demand

One of the primary factors propelling the GI devices market is the growing burden of gastrointestinal diseases worldwide. Conditions such as colorectal cancer, gastroesophageal reflux disease (GERD), and inflammatory bowel disease (IBD) are becoming more prevalent due to aging populations, dietary changes, and sedentary lifestyles. For instance, colorectal cancer remains a leading cause of cancer-related deaths, necessitating enhanced screening tools like high-definition endoscopes and AI-assisted lesion detection. Additionally, the increasing adoption of endoscopic procedures for early disease detection is driving demand for high-precision diagnostic and therapeutic devices. The trend toward outpatient and ambulatory GI procedures is also boosting market growth, as healthcare providers seek cost-effective and efficient solutions.

Technological innovations and AI-powered endoscopy driving market expansion

AI-driven advancements in gastrointestinal devices are revolutionizing diagnostics and treatment approaches. AI-powered endoscopy enhances polyp detection accuracy, reducing false-negative rates and improving early diagnosis of GI cancers. AI algorithms can analyze endoscopic images in real-time, offering decision support to physicians and improving procedural efficiency. Additionally, the development of robotic-assisted endoscopy is enhancing precision in minimally invasive GI surgeries, reducing recovery times and improving patient outcomes. Another key advancement is the adoption of single-use endoscopes, which eliminate the risk of cross-contamination and the need for costly sterilization processes. Innovations like biodegradable GI stents and 3D imaging-guided interventions further expand treatment options, making gastrointestinal procedures safer and more effective. These technological strides are enhancing clinical outcomes and accelerating market adoption across hospitals and ambulatory surgical centers.

Competitive Landscape Analysis

The global gastrointestinal devices market is marked by the presence of established and emerging market players such as Olympus Corporation; Fujifilm Holdings Corporation; Hoya Corporation (PENTAX Medical); Stryker Corporation; Boston Scientific Corporation; Medtronic Plc; Cook Group Incorporated; CONMED Corporation; Johnson & Johnson (Ethicon Inc.); and Cantel Medical Corporation among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

Get PDF Report for Competitive Analysis:
https://meditechinsights.com/gastrointestinal-devices-market/request-sample/

Global Gastrointestinal Devices Market Segmentation

This report by Medi-Tech Insights provides the size of the global gastrointestinal devices market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product type, application, and end-user.

Market Size & Forecast (2023-2030), By Product Type, USD Million

  • GI Endoscopes
  • Laparoscopes
  • Biopsy Devices
  • Endoscopic Retrograde Cholangiopancreatography (ERCP)
  • Others

Market Size & Forecast (2023-2030), By Application, USD Million

  • Diagnostic
  • Therapeutic

Market Size & Forecast (2023-2030), By End-user, USD Million

  • Hospitals
  • Diagnostic Centers
  • Others

Market Size & Forecast (2023-2030), By Region, USD Million

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com

Comments

Post a Comment

Popular posts from this blog

Global Biotechnology Market to grow at 13–15% CAGR as CRISPR use expands globally by 2029

  The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years.  Advancements in genetic engineering and genomics; growing demand for biopharmaceuticals; rising incidence of chronic diseases; growth in environmental and agricultural biotechnology; increased investment in R&D; growing demand for synthetic biology; and presence of favorable government initiatives are some of the key factors driving the biotechnology market. Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop r...
Post a Comment
Read more

Global Multi Cancer Early Detection Market expanding 15–20% CAGR through personalized care 2030

  The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period.  This growth is primarily due to the rising awareness and increasing demand for early-stage screening tools, especially as cancer rates continue to rise globally, and technological advancements in screening methods. However, high costs and strict regulations can still hinder the market growth.  Multi Cancer Early Detection (MCED) refers to tests designed to detect multiple cancers, often from a single blood sample, unlike traditional methods, which can include multiple diagnostic tests or biopsies. These tests look for signs like DNA methylation patterns or small traces of tumor DNA floating in the bloodstream. The primary goal is early cancer detection, ideally before any symptoms appear, so the overall treatment is more effective and less expensive. Download a free sample report now 👉 https://meditechinsights.com/multi-cancer-early-detection-marke...
Post a Comment
Read more

Global Structural Heart Devices Market growth 9% CAGR with favorable reimbursement scenarios 2030

  The global structural heart devices market is set to witness a CAGR of ~9% in the next 5 years.  The rising geriatric population & corresponding rise in the prevalence of heart disease, technological advancements in structural heart devices, regulatory approval for expanded indications for several transcatheter heart valves, and increasing awareness and favorable reimbursements for these procedures in key markets are some of the pivotal factors driving the growth of the structural heart devices market. However, high device costs, complex procedures, and stringent regulatory hurdles continue to restrain market uptake.  Structural heart disease occurs when something is wrong with one’s heart valves, walls, chambers or muscles. It exists from birth or develops as one age. It includes conditions such as congenital heart disease, cardiomyopathy, and heart valve disease. Heart valve devices, occluders & delivery systems, annuloplasty rings, heart access systems, cl...
Post a Comment
Read more